Venture • Life Science

TPG Invests In Nodality

On March 22, 2010, private equity firm TPG invested in life science company Nodality

Investment Context
  • This is TPG’s 21st transaction in the Life Science sector.
  • This is TPG’s 101st transaction in the United States.
  • This is TPG’s 34th transaction in California.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary

Date March 22, 2010
Target Nodality
Sector Life Science
Investor(s) TPG
Deal Type Venture

Target Company

Nodality

San Francisco, California, United States
Nodality is a biotechnology company, discovers and develops personal diagnostics in cell-signaling pathway nodes detected in cellular subpopulations from patients. Nodality focuses on hematological and autoimmune disorders. Nodality was founded in 2003 and is based in San Francisco, California.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

TPG

Fort Worth, Texas, United States

Investor Investor Investor Investor


Category Private Equity Firm
Founded 1992
PE ASSETS 296.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

TPG Capital is a global, mega-sized private investment firm that manages a family of funds focused on private equity, real estate, venture capital, public equity and debt investing. TPG invests in opportunities across a broad range of industries and geographies. TPG generally seeks to invest in established businesses that can benefit from the Firm's operational experience and connections. Industries of interest include consumer, retail, healthcare, industrials, digital media, natural resources, energy, real estate, technology, and software. TPG was formerly known as Texas Pacific Group and was originally established in 1992 by David Bonderman, James Coulter and William Price. The Firm is based in Forth Worth, Texas with additional offices in Europe, Asia, and Australia.


Deal Context for Investor #
Overall 143 of 453
Sector: Life Science 21 of 46
Type: Venture 37 of 93
State: California 34 of 88
Country: United States 101 of 299
Year: 2010 3 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-03-10 Parkway

Singapore, Singapore

Parkway is a healthcare groups with a dominant position in the Singapore private healthcare market through its operation of three hospitals - East Shore, Gleneagles, and Mount Elizabeth Hospitals. Parkway also owns and operates a network of regional hospitals and medical centres in Malaysia, India, China, Vietnam and Brunei.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-03-25 Genomatica

San Diego, California, United States

Genomatica is a sustainable chemicals company that develops technologies to transform chemical production through bio-manufacturing. Genomatica was founded in 2000 and is based in San Diego, California.

Buy -